Etzl, S.; Lindner, R.; Nelson, M. D.; Winkler, A.: Structure-guided design and functional characterization of an artificial red light–regulated guanylate/adenylate cyclase for optogenetic applications. The Journal of Biological Chemistry 293 (23), pp. 9078 - 9089 (2018)
Eilers, Y.; Ta, H.; Gwosch, K. C.; Balzarotti, F.; Hell, S. W.: MINFLUX monitors rapid molecular jumps with superior spatiotemporal resolution. Proceedings of the National Academy of Sciences of the United States of America (2018)
Brieke, C.; Tarnawski, M.; Greule, A.; Cryle, M. J.: Investigating Cytochrome P450 specificity during glycopeptide antibiotic biosynthesis through a homologue hybridization approach. Journal of Inorganic Biochemistry (2018)
At the MPI for Medical Research, physicists, chemists and biologists create knowledge of long-term relevance to basic medical science. With the arrival of three new directors in 2015/16, the institute has a new unifying theme: observing and controlling the vastly complex macromolecular interactions in the context of cells - both in health and disease. The presently four departments contribute to this goal through their complementary expertise: optical microscopy with nanometer resolution (Stefan Hell), the design of chemical reporter molecules (Kai Johnsson), macromolecular structure determination (Ilme Schlichting), cellular, materials and biophysical sciences (Joachim Spatz). The institute has a distinguished history of fundamental breakthroughs, evidenced by six Nobel Prizes awarded to its researchers since its foundation.
The Max Planck Institute for Medical Research is the initiator and speaker of the Max Planck School MATTER to LIFE. The Max Planck Schools are a new, joint initiative of the Max Planck Society, German universities and non-university research organizations. They give graduate education in Germany a completely new direction with a new concept uniquely attractive for outstanding doctoral candidates worldwide. Find more information here.